blog

We regretfully note the death of Carlos F. Barbas III, who passed away at the age of 49 last month after suffering from a rare form of medullary thyroid cancer.

An award-winning and renowned organic chemist, Carlos worked towards developing novel drugs to treat human disease; among his accomplishments are the development of new classes of drugs, either approved for clinical use already or under current trial, and the foundation of three new pharmaceutical companies. He joined the Chemical Biology Faculty in 2004 and authored over 40 recommendations on F1000Prime.

We offer our deepest sympathy to his family, friends and colleagues.

For more information on Carlos and his work, please see The Scientist‘s article and The Scripps Research Institute’s announcement.